Zhitong Finance App News, Wei Xinkang (603676.SH) issued an announcement. Recently, Inner Mongolia Baiyi Pharmaceutical Co., Ltd. (hereinafter referred to as “Baiyi Pharmaceutical”), a wholly-owned subsidiary of the company, received the “Notice of Termination of Drug Registration Application” issued by the State Drug Administration (hereinafter referred to as the “State Drug Administration”), agreeing to Baiyi Pharmaceutical's withdrawal of the pediatric compound amino acid injection (20AA) registration application.

Zhitongcaijing · 05/09 08:01
Zhitong Finance App News, Wei Xinkang (603676.SH) issued an announcement. Recently, Inner Mongolia Baiyi Pharmaceutical Co., Ltd. (hereinafter referred to as “Baiyi Pharmaceutical”), a wholly-owned subsidiary of the company, received the “Notice of Termination of Drug Registration Application” issued by the State Drug Administration (hereinafter referred to as the “State Drug Administration”), agreeing to Baiyi Pharmaceutical's withdrawal of the pediatric compound amino acid injection (20AA) registration application.